TWO SIGMA INVESTMENTS, LP - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$2,708,000
+62.2%
660,601
+41.3%
0.01%
+100.0%
Q4 2021$1,670,000
-58.1%
467,655
-57.3%
0.00%
-55.6%
Q3 2021$3,984,000
-31.3%
1,094,510
-17.7%
0.01%
-30.8%
Q2 2021$5,798,000
+1.9%
1,329,845
-3.9%
0.01%
-13.3%
Q1 2021$5,689,000
+32.4%
1,384,127
+28.5%
0.02%
+25.0%
Q4 2020$4,298,000
+40.3%
1,077,153
-5.1%
0.01%
+9.1%
Q3 2020$3,064,000
-12.8%
1,134,976
-11.1%
0.01%
-35.3%
Q2 2020$3,512,000
-1.3%
1,277,070
-15.3%
0.02%
-41.4%
Q1 2020$3,560,000
-61.9%
1,508,476
-24.0%
0.03%
+3.6%
Q4 2019$9,334,000
+922.3%
1,986,035
+627.4%
0.03%
+833.3%
Q3 2019$913,000
-46.4%
273,046
-47.3%
0.00%
-50.0%
Q2 2019$1,704,000
-18.7%
518,013
-25.1%
0.01%
-14.3%
Q1 2019$2,095,000
+25.1%
691,293
+12.3%
0.01%0.0%
Q4 2018$1,674,000
+89.8%
615,462
+134.3%
0.01%
+250.0%
Q3 2018$882,000
-40.3%
262,632
-42.4%
0.00%
-60.0%
Q3 2017$1,477,000
+322.0%
455,720
+319.3%
0.01%
+400.0%
Q2 2017$350,000
+900.0%
108,685
+173.8%
0.00%
Q1 2016$35,000
-50.7%
39,692
-32.1%
0.00%
Q4 2015$71,000
-64.7%
58,477
+17.7%
0.00%
-100.0%
Q3 2013$201,00049,6680.00%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders